About
Partner and Chartered/European Patent Attorney at Mewburn Ellis LLP who specialises in life sciences and biopharma patent work across discovery, clinical development and regulatory approval, with experience in drafting, prosecution, global portfolio management and IP agreements. He is the firm’s Chief Inclusion & Diversity Officer, a signatory to the IP Inclusive Senior Leader’s Pledge and was recognised as a WIPR Diversity 2022 Champion.
Practice areas
Intellectual PropertyLife Sciences
Office
Expertise
Biopharma / PharmaceuticalsDrug Discovery & DevelopmentAntibody Therapeutics (Antibody-Drug Conjugates; Oncology, Immune-Oncology)Industrial Fermentation (Amino Acid & Bioethanol)Biotherapeutic Separation & Purification (Flow-Filtration)Patent Drafting, Prosecution & Global Portfolio ManagementIP Agreements & Due DiligenceKorean Biopharma & Patent Sector Expertise
Education
- Masters in Biochemistry, University of Oxford
- Masters in Philosophy, University of Cambridge
- PhD, University of Cambridge (cellular developmental biology)
Admissions
- Chartered Patent Attorney (qualified 2010)
- European Patent Attorney (qualified 2011)
- Elected Member, Society of Biology (MSB)